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NEUROPSYCHOPHARMACOLOGY REVIEWS
Genetics of the human circadian clock and sleep homeostat
Liza H. Ashbrook1, Andrew D. Krystal1,2,3, Ying-Hui Fu1,3,4 and Louis J. Ptáček1,3,4
Timing and duration of sleep are controlled by the circadian system, which keeps an ~24-h internal rhythm that entrains to
environmental stimuli, and the sleep homeostat, which rises as a function of time awake. There is a normal distribution across the
population in how the circadian system aligns with typical day and night resulting in varying circadian preferences called
chronotypes. A portion of the variation in the population is controlled by genetics as shown by the single-gene mutations that
confer extreme early or late chronotypes. Similarly, there is a normal distribution across the population in sleep duration. Genetic
variations have been identified that lead to a short sleep phenotype in which individuals sleep only 4–6.5 h nightly. Negative health
consequences have been identified when individuals do not sleep at their ideal circadian timing or are sleep deprived relative to
intrinsic sleep need. Whether familial natural short sleepers are at risk of the health consequences associated with a short sleep
duration based on population data is not known. More work needs to be done to better assess for an individual’s chronotype and
degree of sleep deprivation to answer these questions.
Neuropsychopharmacology (2019) 0:1–10; https://doi.org/10.1038/s41386-019-0476-7
INTRODUCTION
Circadian rhythms
Nearly all living animals, from mammals to prokaryotes, have an
internal clock adapted to the Earth’s rotational schedule of 24 h
[1]. This internal circadian rhythmicity allows the body to predict
the external environment, including when the sun will rise and set,
and to anticipate the best times to sleep, wake, eat, and be active.
The suprachiasmatic nucleus (SCN), located in the hypothalamus,
is the central circadian pacemaker. Bilateral lesions of the SCN in
hypothalami of rodents result in elimination of nocturnal and
circadian rhythms in drinking, locomotive behavior, and hormone
release [2, 3]. The SCN helps coordinate these rhythms throughout
the body down to the cellular level, and SCN outputs target many
tissues including the liver, adrenal glands, and pineal gland [4].
The human circadian pacemaker keeps an average rhythm that
is slightly longer than 24 h with interindividual variability [5, 6].
Therefore it requires external cues, called zeitgebers (time givers),
to continually synchronize to the environment. The strongest
entraining signal for the SCN is light. The retina contains
specialized nonimage forming cells, called melanopsin-expressing
retinal ganglion cells or intrinsically photosensitive retinal gang-
lion cells (ipRGCs), that project to the SCN directly through the
retino-hypothalamic tract [7, 8]. These ipRGCs are primarily
responsive to blue wavelengths of light. The impact of light on
sleep timing follows a phase response curve (Fig. 1) in which light
in the 8–10 h prior to the minimum core body temperature, which
typically occurs about 2 h before habitual wake time, will delay the
circadian clock. Light in the ~9 h following core body minimum
temperature will advance the clock [9, 10]. This effect is maximal
at about 4 h before and after core body temperature minimum,
thus artificial light in the evening and overnight will delay the
circadian clock, resulting in the urge to sleep at a later hour, and
light in the first 2 h of the day will advance it, resulting in an urge
to sleep at an earlier hour [9, 10]. Other factors including exercise
and eating also serve as zeitgebers. While research and treatments
have focused primarily on light, which provides the major input to
the SCN, a phase response curve has been described for exercise
too, in which exercise at 7 a.m. and 1–4 p.m. advances the
circadian clock and exercise from 7 to 10 p.m. delays it [11].
Interestingly, the timing of sleep and wake do not have a clear
influence on the circadian clock.
Chronotype
Chronotype describes the timing of behaviors that manifest from
one’s circadian rhythm, most notably the tendency to sleep and
eat at certain hours of the day. The variance in chronotype
throughout the population follows a normal distribution [12, 13]. It
is linked with light exposure, therefore population norms varying
by longitude, latitude, and city- and rural-dwelling. The mid-sleep
time on free days corrected for work-week sleep loss (MSFSC) is 4
min earlier (on average) for each degree of longitude within a time
zone, accounting for the earlier sunrise [14]. The person-to-person
variation is based on several factors including the duration of an
individual’s internal period of oscillation, termed τ or tau. While
averaging 24.2 h [1, 15], τ is unique to each individual and may be
just over 23 h or extend beyond 25 h [16, 17]. Response to
zeitgebers, angle of entrainment, and amplitude of τ also have an
impact on an individual’s chronotype.
The two-process model: the interaction of circadian forces and
sleep homeostasis
The two-process model, first described by Borbely in 1982, puts
forth a description of sleep regulation that relies on both the
circadian system (termed process C) and sleep homeostasis
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(termed process S) [18]. Process C is dependent on the ~24-h
rhythmic variation of propensity to sleep, and this is balanced with
process S, which increases as a function of time awake. Process S is
estimated by EEG slow-wave activity and has an exponential
decline during sleep. The model posits that it is the interaction of
process C and process S that determines when we wake and when
we sleep. It explains that circadian factors help us stay awake
throughout the day as sleep pressure, modeled by process S,
builds up and also help us stay asleep in the latter part of the
night once this sleep pressure has largely declined. Sleep pressure
also explains why more time awake can lead to more and
deeper sleep.
Modern stressors on the two-process model
Modern society’s reliance on artificial lighting and reduced
reliance on the rising and setting of the sun has put increased
stress on this balance between circadian and homeostatic
pressures. Indoor lighting is typically around 400 Lux, far weaker
than the 10,000 to over 100,000 Lux of sunlight. Given that light is
the main zeitgeber for our circadian system, and most of the light
we experience day to day is artificial light, the overall input to the
circadian system is far weaker than it was for our ancestors
exposed to even cloudy skies on a daily basis [19]. In addition,
light suppresses melatonin release by the pineal gland which can
further influence the timing of sleep [20].
Social and occupational obligations can also alter sleep patterns
and contribute to desynchrony between the internal rhythm and
the timing of sleep for an individual. With reduced external input
and increased evening obligations, the majority of people trend
towards later bedtimes and later wake times. Under natural light
conditions, such as when camping without artificial light,
individuals have been shown to have a 2 h advance in dim light
melatonin onset (DLMO), a marker of circadian phase, compared
with typical conditions with artificial light [21]. There is greater
variation in the timing of both melatonin onset and sleep under
artificial light conditions compared with natural light conditions,
suggesting that the weaker zeitgebers in the artificial lighting
environment allow individual circadian differences to emerge.
Increased time spent outside correlates with earlier chronotypes
[12]. Work and school start times have not changed with
increasing indoor lighting, causing shorter sleep duration for
many people and increased difficulty arising in the morning.
Approximately 20% of the population reports obtaining at least 1
h less sleep than their subjective sleep need, indicating these
external demands are straining the system [22].
Understanding of the mechanism and control of the circadian
system has progressed significantly since Borbely’s model in 1982,
yet sleep homeostasis still remains very poorly understood. Here
we discuss how the circadian system can vary across the
population and lead to extreme phenotypes through genetic
variation, sometimes resulting in disorders of sleep and wake. We
will also discuss how sleep homeostasis can vary across the
population, resulting in short and long sleep need, an area with
increasing evidence that merits far more study.
VARIATIONS IN SLEEP TIMING AND DURATION
Circadian variation
Variations in τ, strength and angle of entrainment, and coupling of
the clock to outputs result in a range of preferred sleep timing
throughout the 24-h day. Extreme early types (called advanced
sleep phase (ASP) or “morning larks”) prefer to go to sleep early
and awaken early. An individual with ASP may sleep 8 p.m. to 4 a.
m. instead of a more conventional 11 p.m. to 7 a.m. Late types
(called delayed sleep phase (DSP) or “night owls”) prefer to go to
bed late and awaken late. An individual with DSP may sleep 4 a.m.
to 12 p.m. The majority of people have a schedule intermediate
between morning larks and night owls (Fig. 2). The exact timing of
what denotes a morning lark or night owl varies by location, and
an intermediate chronotype in Eastern Europe has a mid-sleep
time of 4 a.m., which is a late chronotype in India where the mean
is closer to 3 a.m. [23].
Variations in chronotype by age, sex, and gender
Chronotype is a life-long trait, though there is variation across
the lifespan. Infants and small children are relative morning
larks, and there is an abrupt shift later in adolescence, peaking
around age 20, following which there is a slow drift back to
earlier sleep–wake tendencies over the subsequent decades
[24]. At each age the distribution across the population remains
stable with the same number of relative morning and evening
types. Across the lifespan, an individual also retains his or her
relative position within the group of similar age and sex. As
individuals age past 65 there becomes greater variation across
the population [24].
The prevalence of morning vs. evening types depends on the
age of the population surveyed. In a sample of 433,268
individuals ages 37–73, 27% identified as definite morning
types, while only 9% identified as definite evening types [25, 26].
In contrast, among college students, there is greater evening
preference than the general population with an even greater
evening trend in freshman compared with seniors [27]. There
are also differences by gender. Men are later chronotypes until
around age 50 after which men and women have similar
chronotypes. Nearly 50% of women self-identify as a morning
person compared with only 40% of men [28]. Just as puberty
tends to appear earlier for girls, eveningness peaks in woman at
age 19.5 and in men age 21 [24].
There are also variations by race, though all ethnicities show an
approximately normal distribution of chronotype. In a report by
Eastman et al., African Americans had an average τ of 24.07 h (N=
32), with no difference between men and woman, compared with
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Caucasians who had an average τ of 24.33 h (N= 31) [29]. There
are also differences by ethnicity in morningness, with African
Americans 1.4 times more likely to identify as morning types (vs.
intermediate) compared with Caucasian [26]. This may be related
to differential response to light, as African Americans show a
larger phase advance in response to bright morning light and
smaller phase delay in response to bright evening light [30]. Short
sleep is also twice as common in African Americans, which is likely
multifactorial with a strong influence of social, cultural, and
environmental factors.
GENETICS OF CIRCADIAN PHENOTYPES
Genetics of ASP
Individuals with ASP who report a family history in a first degree
relative are considered to have familial ASP (FASP). While genetic
and environmental factors both contribute, those whose early
chronotype started at a young age are very likely to have a strong
family history of this trait [31]. Many with ASP and FASP do not
find earlier sleep and awakening troublesome, and these
individuals do not typically come to medical attention. Among a
population presenting to a sleep clinic, the prevalence of ASP,
defined as onset of sleepiness by 8:30 p.m. and spontaneous
awakening by 5:30 a.m. with this tendency beginning prior to age
30, is estimated to be 0.33–0.5%. The estimated prevalence of
FASP in this population is at least 0.21% with the majority of ASP
individuals having a family history (Table 1) [31].
The two major methods shedding light on the genetics of ASP
are single-gene mutations determined from families with an
autosomal dominant inheritance pattern and genome-wide
association studies (GWAS). In 1999 the first paper identifying a
Mendelian inheritance pattern of FASP was published [16]. The
proband from the largest identified family was noted to have a τ
of 23.3 h when studied in temporal isolation. At that time, genetic
mutations leading to alterations in the circadian period had been
generated in forward genetic screens in Drosophila and rodents
but no clock gene mutations were yet identified in humans [32].
Linkage analysis led to genetic mapping of the first FASP allele to
chromosome 2q and positional cloning led to identification of
PER2, a homolog of the Drosophila period gene. A mutation that
substitutes a serine with a glycine residue at amino acid position
662, within the casein kinase Iδ/ε (CKIδ/ε) binding region of PER2,
was identified in affected members of the first FASP family [33].
This mutation was engineered into mice and led to a semidomi-
nant ASP trait, recapitulating the phenotype of the humans
harboring the mutation [34]. Further study suggests this mutation,
PER2S662G, is a stronger transcriptional repressor than wild-type
PER2, supporting the role of PER2 in setting the speed of the
molecular clock [35].
Many additional families have been identified with a similar
pattern including an allelic series of PER2 mutations, but most
FASP families do not have a recognized mutation in PER2. Study of
these families has shown genetic heterogeneity and led to
identification of multiple additional causative mutations. Muta-
tions leading to FASP have been identified in four additional
genes, CK1δ (also known as CSNK1D) (T44A), PER3 (P415A/H417R),
CRY2 (A260T), and TIMELESS (R1081X) [35–38]. These mutations are
present in only a small minority of a large FASP family cohort,
suggesting there are novel human circadian alleles and potentially
novel genes yet to be identified.
Several circadian genes have pleiotropic effects influencing
other aspects of health and disease. Mutations conferring an FASP
phenotype have been show to cosegregate with migraine and
depression. In two of the families with a Mendelian inheritance
pattern of FASP, identification of the cosegregation of migraines
with the extreme morning lark trait led to the identification that a
mutation in CK1δ confers both migraine and FASP in the affected
individuals [39]. The two identified families have distinct missense
mutations, T44A and H46R, and mice engineered to carry one of
these mutations were more sensitive to pain when a typical
migraine trigger was provided. They also demonstrated reduced
thresholds for inducing cortical spreading depression, the
physiology underlying migraine aura. FASP, depression, and
seasonal mood traits have also been linked in two variants in
the PER3 gene [37]. This causes seasonal affective disorder in
humans and a depression-like phenotype in mice that worsens
under shorter photoperiods.
GWAS of chronotype. Multiple recent GWAS, relying on large
cohorts such as the UK Biobank and the “direct to consumer”
genetic testing company 23andMe, have identified many loci that
show an association with morningness [28, 40–42]. The work,
compiling up to 697,828 individuals in a single study, primarily
derives chronotype by asking about self-reported morning or
evening preference. In a more limited sample, activity-monitor
derived sleep preference is also used [43]. Through this work,
morningness has been associated with lower rates of depression
and with better mental health [28, 42].
Up to 351 loci have shown association with chronotype in
GWAS studies. These include PER2, PER3, and Cry1, already
known to cause FASP or familial DSP (FDSP) in familial studies.
CK1δ, Cry2, and TIMELESS mutations, also identified as causative
in individual FASP families, have not been identified through
GWAS. Notably, many loci found to be associated with
chronotype in GWAS have not been replicated in independent
cohorts. This suggests genetic complexity and may also be
related to systematic biases depending on the tools used for
defining chronotype. However, several genes arise in multiple
studies. Four large GWAS published in the last 4 years found loci
near the PER2, FBXL13, RGS16, and AK5 genes [28, 40, 41, 43]. As
PER2 is already established to be involved in the circadian clock
and causative of FASP, it seems likely that this association is a
direct effect via PER2. RGS16 is involved in signaling in the SCN
and FBXL13 is associated with lengthened circadian period in
Table 1. Prevalence and known Mendelian genes in familial advanced
sleep phase (FASP), familial delayed sleep phase (FDSP), and familial
natural short sleep (FNSS)
FASP FDSP FNSS
Hours of sleep 7–9 h 7–9 h 4–6.5 h
Prevalence 0.21–0.5% Unknown Unknown
Mendelian genes PER2, CK1δ, PER3, CRY2,
TIMLESS
CRY1 DEC2,
ADRB1
6PM 9PM 12AM 6AM 12PM
Advanced sleep  phase
Delayed sleep phase
Hour of the day
Natural short
sleep
Conventional sleep period
3AM 9PM
Fig. 2 Typical sleep period timing compared with delayed sleep
phase, advanced sleep phase, and natural short sleep
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mice [44]. Interestingly, AK5 is a gene not previously known to
be involved in the circadian system prior to this work [45]. At
least three studies have shown involvement of hypocretin
receptor type 2, known to be involved in alertness and also
associated with sleep duration via GWAS study; [46] 5-
hydroxytrptamine (serotonin) receptor 6, known to be involved
in sleep regulation though not circadian regulation; and
trinucleotide repeat containing 6b, previously shown to have
involvement in the circadian system in Drosophila and mice. A
remaining and daunting challenge of this field is the elucidation
of pathways relevant to chronotype in the region of an
associated locus. It will not always be the case that the closest
gene to an associated locus will be causative for the chronotype.
Genetics of DSP
DSP, when more extreme, is also commonly a life-long tendency,
worsening during adolescence and lessening with age. When DSP
exists in a first degree relative it is termed FDSP. Prevalence
estimates for DSP vary by definition, location, and age, but range
up from as low as 0.13 to 3.1% [47].
In twin studies, genetic factors account for about 50% of diurnal
preference [48, 49]. Despite this, fewer genes have been identified
that lead to DSP than ASP. This suggests DSP is likely multigenic
with several genes each playing a smaller role, though nongenetic
factors such as artificial evening lighting and social pressures
confound the picture making the detection of genetic variants
more challenging. A length polymorphism in the PER3 gene due
to a variable-number tandem repeat (4 or 5 repeats) has been
linked to DSP in which the longer allele is associated with
morningness and the shorter allele with eveningness [50]. A
missense PER2 variant, Rs35333999, is associated with longer
circadian period and later chronotype [40, 51]. A single mutation
in the CRY1 gene, CRY1 c.1657+ 3 A > C, has been identified that
confers an autosomal dominant DSP trait [52]. This allele has a
prevalence of 0.6%, so is predicted to be responsible for a fraction
of FDSP in the general population. The frequency of FDSP is not
known and thus, it is not clear what proportion of this trait is
explained by this CRY1 variant.
Circadian misalignment
The terms ASP and DSP are descriptions of preferred sleep timing
and do not describe pathology. However, society has conventional
hours of operation, and if an individual is not able to sync with this
schedule, it can make the regular routine of life more challenging
as propensity for sleep may fall in daylight and highest alertness in
darkness. When this causes complaint, distress or trouble with
function, it is termed circadian misalignment.
Advanced sleep wake phase disorder
A subset of ASP individuals present to their doctor with a
sleep–wake complaint such as evening sleepiness, bothersome
early morning awakenings not from another cause such as
depression, insomnia, or sleep apnea, or daytime sleepiness
from insufficient sleep due to trying to stay up for social, family,
or work obligations. This subset with a complaint related to
their early circadian timing meet criteria for advanced
sleep–wake phase disorder (ASWPD) in the International
Classification of Sleep Disorders (ICSD-3) [53]. One in eight
with ASP meet criteria for ASWPD, suggesting a prevalence of at
least 0.04% or 1/2500 (Table 2) [31]. This prevalence estimate
does not account for those who become advanced only in later
years as part of the common phase advance associated with
aging (ASP of aging). Only those individuals who complain of
this trait will carry the diagnosis of ASWPD. Figure 3 details the
relationship between FASP, ASWPD, and ASP of aging. The
relative size of the circles in Fig. 3 does not reflect the relative
prevalence of FASP, ASWPD vs. ASP of aging, as the prevalence
of ASP of aging is not known.T
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Delayed sleep–wake phase disorder (DSWPD)
For those who have a related complaint of insomnia or daytime
sleepiness and feel better when allowed to sleep on their chosen
delayed sleep schedule, the ICSD-3 classification is DSWPD [53]. This
is a far more common complaint than ASWPD, and it is estimated
that ~10% presenting with insomnia have DSWPD [53]. The
prevalence of DSWPD varies by population but ranges from 7 to
16% among adolescents and young adults [53]. It is likely that a
larger proportion of those with DSP have a complaint compared
with those with ASP due to several factors. It is harder to live on a
“conventional” schedule (typical school or work start times) for
individuals with DSP than those with ASP. The increase in evening
artificial light helps ASP individuals delay, keeping them closer to a
conventional schedule, while evening light only further exacerbates
the misalignment for those with DSP. Also, those with DSP
experience greater sleep inertia, the phenomenon of a delay to
feeling fully alert after awakening, compared with those with ASP
[12]. While ASP individuals commonly feel alert within seconds or
minutes of waking, those with DSP may take minutes to hours [31].
Other alterations of circadian rhythms
Some individuals are not able to entrain to a 24-h day and instead
of having a stably advanced or delayed schedule, their sleep
timing is continually shifting, resulting in alternating insomnia and
excessive daytime sleepiness. This is termed non-24 sleep–wake
disorder (N24SWD) [53]. Typically this occurs with rhythms over
24 h and most who suffer from N24SWD are totally blind and
cannot entrain due to lack of the entraining input from light to the
SCN. While the incidence of N24SWD is not known, over half of
blind individuals do complain of sleep disturbance. Less com-
monly, some individuals are not able to entrain due to dementia,
developmental abnormalities, or psychiatric disorders. Those with
developmental delay and neurodegenerative disease may also
suffer from irregular sleep–wake rhythm disorder in which the
affected individual sleeps throughout the 24-h day and does not
have a day vs. night preference [53]. This problem has also been
reported following traumatic brain injury [54].
Impact of circadian misalignment on health
Circadian misalignment has negative health impacts. Causes of
misalignment include shift work and social jetlag. Epidemiologic
data reveals higher incidence of ischemic heart disease, metabolic
syndrome, obesity, and cancer among shift workers [55–58].
Sleeping out of phase with one’s biological circadian rhythm has
been shown to decrease leptin, increase insulin resistance, and
increase mean arterial pressure [59]. Misalignment may influence
breast cancer progression and long-term rotating night shift
workers have a higher risk of breast cancer [60, 61]. Lack of
entrainment, as demonstrated by melatonin rise during nonsleep
hours, correlates with impaired learning and memory [62].
Destabilization of circadian rhythmicity may be a factor in tumor
progression as the circadian rhythmicity of multiple circadian
genes has been noted to be lower or absent in cancer cells [63].
Misalignment can occur between an individual and the
environment, such as with ASWPD, DSWPD, or shift work, and
within an individual, called internal misalignment. The SCN is
responsible for synching internal physiologic processes including
feeding and fasting, and peripheral clocks are subservient to the
SCN. The body anticipates nightly fasting and stimulates
gluconeogenesis, putting lipids and glucose levels under tight
circadian control [64, 65]. This is demonstrated by mice with a liver
specific deletion of the essential clock gene Bmal1 who developed
hypoglycemia during fasting [66]. While light is the major input to
the SCN, food is the most important input to peripheral oscillators.
When meals are not synchronized to the light driven SCN,
peripheral clocks can become decoupled. For example, when
rodents are put on a restricted feeding schedule in which the
timing of food offering is not synched with expected timing by the
light cycle, the SCN remains synched with light but multiple
peripheral oscillators including the liver, kidney, heart, and
pancreas become synched with the eating schedule [67, 68]. This
desynchrony with the liver has been shown to contribute to
metabolic consequences such as obesity and type 2 diabetes [69].
Impact of chronotype on health
Chronotype alone also appears to impact disease. Recent work
suggests decreased well-being, shorter lifespan, and increase
mortality in evening types [25, 70]. There are higher rates of a
wide range of disorders including psychological disorders,
diabetes, neurological, gastrointestinal, and respiratory in definite
evening types compared with definite morning types [25].
Morning preference appears to have a protective effect against
breast cancer using a Mendelian randomization study model to
investigate the impact of chronotype on breast cancer diagnosis
in the UK Biobank [71]. Within diseases, such as bipolar and
chronic migraine, evening type may impact frequency of episodes
[72, 73]. Whether this negative impact of evening chronotype is
mediated by increased misalignment is not known.
Clinical evaluation of circadian misalignment
When patients in clinic complain of trouble falling asleep,
staying asleep, early morning awakenings, or daytime sleepi-
ness, chronotype is an important factor to consider in devising
optimal treatment. However, it can be difficult to determine an
individual’s chronotype. There are many tools used for this
purpose currently, but all have limitations. The timing of sleep
is one tool. To characterize chronotype, it is important to ask
about timing of first falling asleep and final awakening on long
weekends or vacations without obligations. It is important to
focus on prolonged time off because weekday and weekend
obligations often shape sleep timing and rebound sleep on the
weekend can prolong sleep. Two questionnaires, the Munich
ChronoType Questionnaire, which generates a mean sleep on
free days (MSF) time, and the morningness–eveningness
questionnaire are used to screen for chronotype. Objective
measures include DLMO, which is considered the most reliable
measure of central circadian timing. Melatonin levels are very
low during the day and start to rise in the evening. The timing
of this rise represents the action of the central circadian
pacemaker, the SCN, which signals the pineal gland to release
melatonin [74]. However, light suppresses melatonin release
[20, 75]. Therefore, this collection must be done at frequent
intervals in the hours before habitual bedtime in dim light
conditions. It is not widely available clinically and is cumber-
some to collect and therefore is not routinely used in clinical
practice. Core body temperature minimum is also a strong
FASP
ASP of
aging
ASWPD
Fig. 3 Diagram of the relationship between familial advanced sleep
phase (FASP), advanced sleep–wake phase disorder (ASWPD), and
ASP of Aging. This figure is adapted from a figure that is reprinted
with permission from the journal SLEEP [31]. Relatives sizes do not
reflect relative prevalence as the prevalence of ASP of Aging is
not known
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indicator of the timing of the central pacemaker. However, this
is difficult to obtain clinically and is not typically done outside
of a research setting. In determining how to treat circadian
disorders, it is also useful to understand the τ of an individual,
but this is difficult to determine as optimal testing requires a
challenging protocol called the forced desynchrony protocol,
carried out only in research settings. This procedure requires an
individual to follow a cycle of rest and activity outside the
range of entrainment of the circadian pacemaker, commonly a
28 h cycle, and measures circadian changes during this
desynchrony [1].
Promising future approaches to identify intrinsic rhythm rely on
the fact that transcription and metabolism are under circadian
regulation in mammals [76, 77]. The transcriptome for mammals
has been characterized [78] and work is underway to utilize this to
better define circadian phase. Nearly half of protein-coding genes
express rhythmicity at some site in the body [79]. Thus, the
transcriptome or metabolome of cells in blood promises to be
useful as a marker for circadian phase. Multiple efforts have been
made on that front. Liang et al. report a whole blood mRNA based
predictor looking at 100 biomarkers, primarily involved in
glucocorticoid signaling and immune function, which can predict
melatonin cycle timing when sampling at two time points 12 h
apart [80]. Braun et al. have created a machine-learning algorithm
that can be trained to use gene expression to predict circadian
rhythms [81]. Wittenbrink and colleagues report a monocyte
NanoString-based gene expression profile based on 12 genes that
can predict circadian timing with a single daytime sample [82].
This approach has the potential to improve detection of
chronotype in routine clinical practice, however no tool is
currently clinically validated and available.
THE SLEEP HOMEOSTAT
Sleep need
Similar to chronotype, habitual sleep duration varies across the
population and follows a normal distribution [83]. In 2015, the
National Sleep Foundation released a recommendation that adults
obtain 7–9 h of sleep [84]. This has led to an important national
conversation about the value of adequate sleep. However, there is
also increased anxiety from those whose biological sleep “need”
does not match these recommendations as not everyone with
short or long sleep need has pathology.
Sleep need: epidemiologic data
The majority of information regarding adequate sleep duration
comes from epidemiologic data and sleep deprivation experi-
ments. Epidemiologic data shows an association between short
and long sleep and increased mortality. The lowest mortality is
for ~7 h of sleep, and deviation from this in both directions is
associated with increased mortality in approximately a u-shaped
distribution [85]. This relationship has been shown in numerous
cultures across the world [86]. There is a similar relationship
between short and long sleep duration and glucose tolerance,
type 2 diabetes, elevated BMI, obesity, and metabolic syndrome
[87–89]. It is important to note that these studies measure an
association in a population of people. It is likely that the optimal
amount of sleep for an individual varies dramatically across the
population.
Epidemiologic data is based on self-reported sleep duration
and does not incorporate a reason for short sleep hours. Thus,
such studies do not differentiate between those who have short
sleep accompanied by a sleep-related complaint, such as
insomnia or excessive daytime sleepiness, and those who do
not. In fact, a u-shaped curve of sleep complaints has also been
reported, indicating many of those reporting short sleep also
complain about trouble with nocturnal sleep or have daytime
sleep-related symptoms [90]. The 5% who report the shortest
sleep duration have a high incidence of insomnia suggesting
that this u-shaped curve may be picking up the comorbidity of
insomnia [91].
Sleep need: sleep deprivation data
The other major factor driving recommendations on sleep
duration is sleep deprivation experiments. Numerous laboratory
studies show that sleep deprivation has negative consequences
for health. Metabolic consequences of acute sleep deprivation
include insulin resistance, endocrine dysfunction, decreased
leptin, increases ghrelin, and increased blood pressure [92–95].
Sleepiness and reduced sleep time have been linked to motor
vehicle accidents [96–98]. Short sleep has been associated with
increased incidence of depression [99]. Acute sleep deprivation
causes sleepiness and deficits in alertness, attention, learning, and
memory [100]. Notably, however, cognitive function tests during
sleep deprivation experiments reveal a range of responses
following sleep loss, with some individuals having minimal
negative consequences. These interindividual differences in
vulnerability to the cognitive effects of sleep loss appear trait-
like, remaining stable over time [101].
Genetic variation in sleep need
We hypothesize that variation in vulnerability to sleep loss may be
related to differences in an individual’s biological requirement for
sleep—ranging from natural short sleep to natural long sleep.
Variable response to sleep loss is, at least in part, genetic. EEG
delta power recorded during non-REM sleep, which increases the
longer an individual has been awake prior to sleeping and
dissipates during non-REM sleep, is a marker of homeostatic sleep
pressure, and interindividual variation around delta power likely
reflects a central factor in sleep need variation. Studies in multiple
inbred strains of mice show that delta power varies by strain with
delta power depending on both prior wake time and genotype
[102, 103]. Mice with a mutation in the clock gene showed
decreased sleep time over 24 h with ~1 h reduction in hetero-
zygotes and a 2 h reduction in homozygotes [104].
In humans, we have known since the 1930s through twin
studies that sleep length is heritable [105, 106]. GWAS data show
10–21% heritability of sleep duration with several clock genes
implicated. A relatively early GWAS published in 2007 with 749
participants shows a SNP in NPSR1 at rs324981 to be associated
with a 15 min later bedtime for each allele present [107]. Two
larger studies compiling data from 47,180 and 446,118 individuals
both show associations of multiple loci with sleep duration,
however the genes and mechanisms remain to be elucidated
[46, 108]. A polymorphism at rs4753426 in a melatonin receptor
gene, MTNR1B, correlates with more time in bed on weekends,
suggesting a potential role in sleep duration, and a separate
variant, rs7942988, has been shown to impact duration of
melatonin secretion [109, 110].
The sleep EEG is remarkably stable for an individual and follows
a trait-like pattern with repeated assessment at baseline and
following sleep deprivation showing reproducible characteristics
[111, 112]. Non-REM EEG delta power was among the most stable
of the sleep parameters for an individual over multiple assess-
ments with the greatest variability between individuals. Much of
this interindividual variability in the sleep EEG is thought to be
driven by genetics [113, 114]. For example, carriers of a common
PER2 variant have 22%, or 20 min, less slow wave sleep (SWS)
compared with noncarriers [110].
There are multiple genes, including PER2 and DEC2, identified as
clock genes that have also been demonstrated to influence the
sleep homeostat and vice versa [33, 110, 115, 116]. This implies a
deep interdependence between the systems. Given the systems
coevolved, this interdependence is not surprising. However the
dynamics of this interplay remain unknown and more study is
needed to better understand this complex relationship.
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Physiologic differences in sleep between short and long sleepers
There has been limited investigation on the physiologic changes
in sleep of habitual short and long sleepers. Familial natural short
sleep (FNSS) is a subgroup within those reporting habitual short
sleep. Thus, this research does not describe FNSS specifically.
Short sleepers have a shorter duration of melatonin release and
earlier times of cortisol peak and temperature nadir compared
with long sleepers [117]. Increased time awake in the short
sleepers leads to higher waking levels of theta and low-frequency
activity. Short sleepers appear to have more spectral power in the
5.25–9.0 Hz and 17.25–18.0 Hz range than long sleepers [118].
Aeschbach et al. investigated how to apply Borbely’s two-process
model to short and long sleepers by completing sleep EEG under
baseline and sleep deprivation conditions [119]. At baseline, short
sleepers slept over 3 h less than long sleepers. This was primarily
made up by differences in REM and stage N2 sleep; SWS did not
significantly differ between groups on any night. With sleep
deprivation, sleep latency and REM density decreased more in
long sleepers than in short sleepers. Short sleepers did have a
shorter sleep latency and a larger amount of SWS when matching
the initial portion of the long sleepers’ nights to the total night for
the short sleepers, suggesting that short sleepers are under higher
sleep pressure. Short sleepers also appeared to awaken with a
higher sleep pressure, suggesting that short sleepers tolerate a
higher homeostatic sleep pressure [119].
Familial natural short sleep
In 2009 the first human genetic variant leading to a short sleeping
phenotype was described in the DEC2 gene, P385R [115]. Fu and
colleagues termed this FNSS. FNSS is defined as a stable trait of
sleeping 4–6.5 h/night without daytime sleepiness or clear
impairments (Table 1). These individuals are sometimes seen in
sleep clinics because they are told they “need” more sleep—they
are sometimes considered insomniacs. However, when these
individuals are asked how they feel after sleeping 4–6.5 h, they
often report feeling “great” and “well rested.” In the first described
family, the DEC2 mutation leads to reduced sleep duration in the
affected individuals. Engineering this mutation in Drosophila and
transgenic mice produces a similar phenotype. DEC2 is a
transcriptional repressor and increases expression of hypocretin
[120]. Hypocretin, also known as orexin, is wake promoting and
involved in sleep–wake transitions. Loss of hypocretin producing
neurons in the lateral hypothalamus leads to narcolepsy with
cataplexy. A novel mutation in DEC2 has also been identified in a
pair of dizygotic twins with the same BMI but in which one twin
had reduced sleep duration, less recovery sleep following sleep
deprivation, and fewer performance lapses following sleep
deprivation [121]. Another mutation causing FNSS has been
identified in the beta 1 adrenergic receptor gene (ADRB1) [122].
ADRB1 is highly expressed in the dorsal pons and the neurons are
active during REM and wake. Multiple additional families with an
autosomal dominant pattern of decreased sleep need have been
collected, and two additional genes have been identified with the
short sleep phenotype recapitulated in mouse models [122].
Individuals with FNSS report decreased sleep need throughout
adult life, some dating to childhood. They report sleep durations
ranging from 4 to 6.5 h per night without daytime sleepiness or
reported deficits from sleep deprivation. FNSS individuals are in
part distinguished from facultative short sleepers by their lack of
catch-up sleep on weekends and free days. They report greater
flexibility around sleep timing and less subjective deficit after
sleep deprivation. They often deny experiencing jetlag (unpub-
lished data). However, it is not just sleep duration that
characterizes this group of individuals. There is a high behavioral
drive among those with FNSS, and individuals report a need to
always be mentally active resulting commonly in high profile,
high pressure jobs or holding multiple jobs. FNSS individuals also
appear to have high pain thresholds and relative resilience to life
stressors (unpublished data). Thus, the phenotype does not only
encompass a sleep pattern but also daytime behavior. Individuals
with short sleep and increased behavioral drive have been
described in the literature as early as 1972 when Hartmann et al.,
while studying sleep need variation, described those who sleep
less than 6 h as “smooth [and] efficient” and with greater
tolerance and flexibility and less depression compared with long
sleepers [123]. It is possible that DEC2, ADRB1 and other causative
mutations all lead to a higher behavioral drive, which allows
those with FNSS to overcome increased homeostatic sleep
pressure though much work needs to be done to test this
hypothesis.
Familial natural long sleep (FNLS)
Similar to short sleep, there is likely a group of individuals who
need a greater amount of sleep. However there are not yet any
identified genetic variants causing FNLS. Comorbidities such as
depression and lifestyle factors complicate the picture making this
group harder to detect.
Despite these knowledge gaps, it is crucial to recognize genetic
and biological differences among people with regard to biological
“need” for sleep to avoid labeling individuals as having pathology
when none exists and to offer appropriate care when there is a
mismatch between sleep need and sleep duration. Additional
understanding about how to define and measure sleep need is
in order.
FUTURE RESEARCH DIRECTIONS
Across the population, there is a normal distribution of chronotype
and habitual sleep duration. Genetics accounts for a lot of this
variation in the population, most clearly at the extremes for
circadian rhythm and short sleep duration. Single-gene mutations
have been found that lead to extreme chronotypes in FASP and
FDSP. Single-gene mutations also cause extremes of sleep
duration in FNSS families and likely FNLS though this is not yet
described in the literature. There are many FASP and FNSS families
with an autosomal dominant pattern of inheritance without an
identified gene, suggesting extension beyond known clock genes.
Forward genetic screens in flies and mice have focused on
mutations with large effects on period or rhythmicity. We
postulate that some of the FASP genes will affect entrainment
or coupling of clock to physiologic outputs. FNSS genes likely
impact behavioral drive, delta power, and sleep efficiency.
There are many unanswered questions regarding variations in
sleep need and FNSS. These include whether those with FNSS are
resistant to any of the reported metabolic and cognitive
consequences of sleep deprivation and whether they are
susceptible to the epidemiologically described long-term health
consequences. We hypothesize they are resistant to many of these
given the observation that they are often high achieving without
any clear medical comorbidities. Better individual and epidemio-
logic studies of this population are merited. Further, under-
standing the possible tolerance to higher sleep pressure and
behavioral drive may have implications for a wide range of
occupations requiring long durations of wakefulness including
pilots, military personnel, and physicians and for treatment of
disorders of sleep and arousal.
We need a conceptual framework for genetic and biologic
contributions to sleep in individuals vs. populations. The current
model of circadian factors and sleep homeostasis does not explain
this third dimension of behavioral drive observed in FNSS. The
circadian clock, sleep homeostat, behavioral drive, and environ-
mental factors such as light exposure and daily obligations
together impact the ultimate timing and duration of sleep (Fig. 4).
Future work should focus on circadian factors affecting entrain-
ment and clock-output coupling and sleep homeostatic factors
affecting biologic sleep need, tolerance of homeostatic sleep
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pressure, and sleep efficiency. Finally, genes and proteins
impacting behavioral drive merit direct investigation.
It is imperative that we did not impose rigid recommendations
for what constitutes a “healthy” amount of sleep or “healthy”
timing of sleep for an individual based on population averages. It is
clear that an individual who does not sleep at his or her ideal
circadian timing or for his or her ideal duration will suffer
consequences. However, given the interindividual variation in the
ideal timing or duration, we need to better understand and
measure an individual’s need. This means we need better tools to
assess chronotype and sleep deprivation, which may ultimately
come from measurements of the transcriptome and proteome. The
identification of Mendelian families with FASP, FDSP, and FNSS
makes clear that there are strong genetic factors affecting sleep
timing and quantity. The variation between the extremes is certain
to result, in part, from complex genetic factors. Identification and
study of additional human circadian and sleep genes causing
extreme phenotypes will lead to better understanding of genes
and pathways regulating sleep timing and quantity in humans.
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